Stocks and Investing
Stocks and Investing
Mon, August 7, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Luke Sergott Maintained (TWST) at Buy with Increased Target to $26 on, Aug 7th, 2023
Luke Sergott of Barclays, Maintained "Twist Bioscience Corporation" (TWST) at Buy with Increased Target from $20 to $26 on, Aug 7th, 2023.
Luke has made no other calls on TWST in the last 4 months.
There are 2 other peers that have a rating on TWST. Out of the 2 peers that are also analyzing TWST, 1 agrees with Luke's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Matthew Sykes of "Goldman Sachs" Maintained at Hold with Increased Target to $20 on, Thursday, July 13th, 2023
This is the rating of the analyst that currently disagrees with Luke
- Catherine Ramsey of "Baird" Maintained at Buy with Decreased Target to $18 on, Monday, May 8th, 2023
Contributing Sources